Myalgia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants must be between 18 and 45 years old. Of either sex. They must have at least six months of regular CrossFit experience, training a minimum of three times per week. It is essential that athletes are considered healthy and do not have any current or chronic musculoskeletal injuries that could interfere with the execution of the Murph WOD or the application of cryotherapy. Participants must not have performed the Murph WOD or similar high-intensity exercises in the four weeks prior to the start of the study. All participants must provide written informed consent, indicating that they understand the study procedures, risks, and benefits. Additionally, they must be available for training sessions, cryotherapy application, and subsequent assessments within the timeframe established by the study. Athletes' body mass index (BMI) must be between 18.5 and 30 kg/m². Participants must not have used cryotherapy regularly as a recovery method in the three months preceding the study. It is important that athletes demonstrate the ability to follow study instructions and protocols consistently and correctly. Participants must be able to read and comprehend the language in which the study and informed consent are presented, ensuring they fully understand all instructions and study requirements
Exclusion criteria
Exclusion criteria: Participants who present any medical condition that may be exacerbated by intense exercise or exposure to cold, such as severe cardiovascular, respiratory, or metabolic diseases, will be excluded. Athletes with a history of chronic or recent musculoskeletal injuries that may interfere with the execution of the Murph WOD or the application of cryotherapy will also be excluded. Individuals who have performed the Murph WOD or similar high-intensity exercises in the four weeks prior to the start of the study will not be eligible. Participants who have regularly used cryotherapy as a recovery method in the three months preceding the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of delayed onset muscle soreness assessed by the Visual Analogue Scale, decreased muscle pain as evaluated by the Brief Pain Inventory, and reduction of muscle pain in the questionnaire for the assessment of musculoskeletal pain in exercise practitioners. | — |
Secondary
| Measure | Time frame |
|---|---|
| Increase in pressure pain threshold and decrease in temperature in the arm and posterior leg regions. | — |
Countries
Brazil
Contacts
Universidade Federal de Alfenas